data13F

RYTM – Rhythm Pharmaceuticals Inc

Held by 2 of 30 tracked investors in their latest 13F filing · 0 counted on Most owned (narrow-view filings excluded)

Investors holding2
Combined shares364,974
Combined reported value$34.8M

RYTM chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Stanley Druckenmiller narrow view 0.62 Added 32.6%269,900$25.7MQ3 2026
Ray Dalio narrow view 0.04 New95,074$9.1MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Added 32.6%269,9000.15
Q3 2026Ray Dalio narrow view New95,0740.04
Q2 2026Stanley Druckenmiller narrow view New203,6180.52

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Stanley Druckenmiller narrow view Added 32.6%269,9000.15
Q3 2026Ray Dalio narrow view New95,0740.04
Q2 2026Stanley Druckenmiller narrow view New203,6180.52

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

2 peakQ3 2026: 2 tracked investors
Q2 2026: 1 tracked investorsQ3 2026: 2 tracked investors
20262026
Tracked investors reporting this stock, by quarter

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Stanley Druckenmiller269.9K203.6K––––––
Ray Dalio95.1K–––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).